La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Poly Medicure Gestione
Gestione criteri di controllo 2/4
Poly Medicure's Il CEO è Himanshu Baid, nominato in Sep1995, e ha un mandato di 28.92 anni. la retribuzione annua totale è ₹ 130.06M, composta da 42.3% di stipendio e 57.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 12.24% delle azioni della società, per un valore di ₹ 24.98B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.2 anni e 10.1 anni.
Informazioni chiave
Himanshu Baid
Amministratore delegato
₹171.8m
Compenso totale
| Percentuale dello stipendio del CEO | 33.6% |
| Mandato del CEO | 29.1yrs |
| Proprietà del CEO | 11.6% |
| Durata media del management | 6.3yrs |
| Durata media del Consiglio di amministrazione | 8.3yrs |
Aggiornamenti recenti sulla gestione
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹172m | ₹58m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹130m | ₹55m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹1b |
| Jun 30 2022 | n/a | n/a | ₹1b |
| Mar 31 2022 | ₹107m | ₹49m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹92m | ₹44m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹1b |
| Sep 30 2020 | n/a | n/a | ₹1b |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹62m | ₹35m | ₹959m |
| Dec 31 2019 | n/a | n/a | ₹947m |
| Sep 30 2019 | n/a | n/a | ₹858m |
| Jun 30 2019 | n/a | n/a | ₹719m |
| Mar 31 2019 | ₹44m | ₹14m | ₹654m |
| Mar 31 2018 | ₹41m | ₹14m | ₹706m |
Compensazione vs Mercato: La retribuzione totale di Himanshu ($USD 1.55M ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 591.43K ).
Compensazione vs guadagni: La retribuzione di Himanshu è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Himanshu Baid (56 yo)
29.1yrs
Mandato
₹171,781,000
Compensazione
Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Director | 29.1yrs | ₹171.78m | 11.6% ₹ 28.8b | |
| Founder & Non Executive Director | no data | ₹1.43m | 2.25% ₹ 5.6b | |
| Chief Financial Officer | 3.3yrs | ₹11.21m | Nessun dato | |
| Company Secretary & Compliance Officer | 9.4yrs | ₹1.88m | Nessun dato | |
| Joint MD & Executive Director | no data | ₹166.82m | 12.39% ₹ 30.8b | |
| President of Corporate Sales & Marketing | 2.5yrs | ₹18.39m | 1.66% ₹ 4.1b | |
| Assistant Vice President of Finance & Accounts | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Domestic Sales & Marketing | no data | ₹5.79m | Nessun dato | |
| President of R&D | no data | ₹5.61m | Nessun dato | |
| President of Sales & Marketing - India | no data | ₹8.61m | Nessun dato |
6.3yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di POLYMED è esperto e expertise (durata media dell'incarico 6.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Director | 29.6yrs | ₹171.78m | 11.6% ₹ 28.8b | |
| Founder & Non Executive Director | 29.6yrs | ₹1.43m | 2.25% ₹ 5.6b | |
| Joint MD & Executive Director | 29.6yrs | ₹166.82m | 12.39% ₹ 30.8b | |
| Non-Executive Independent Director | less than a year | Nessun dato | Nessun dato | |
| Non-Executive Independent Director | 4.3yrs | ₹1.60m | Nessun dato | |
| Non-Executive Independent Chairman | 19.4yrs | ₹1.63m | Nessun dato | |
| Non-Executive Director | 10.3yrs | ₹1.43m | 3.02% ₹ 7.5b | |
| Non-Executive Independent Director | 4.2yrs | ₹1.45m | Nessun dato | |
| Non-Executive Non Independent Director | 6.4yrs | ₹29.90m | Nessun dato | |
| Independent Director | 2.5yrs | ₹1.45m | Nessun dato |
8.3yrs
Durata media
64.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di POLYMED sono considerati esperti (durata media dell'incarico 8.9 anni).